What Analyst Projections for Key Metrics Reveal About Vertex (VRTX) Q1 Earnings

In its upcoming report, Vertex Pharmaceuticals (VRTX) is predicted by Wall Street analysts to post quarterly earnings of $4.22 per share, reflecting a decline of 11.3% compared to the same period last year. Revenues are forecasted to be$ 2.82 billion, representing a year-over-year increase of 4.8%.Over the last 30 days, there has been an upward revision of 0.2% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of the ...